P&K Skin Research Center피엔케이피부임상연구센타
347740 · KOSDAQ · ₩347740 · 피엔케이피부임상연구센타
- Market cap
- ₩53B
- Enterprise value
- ₩20B
- P/E
- 14.2×
- P/B
- 0.6×
- Dividend yield
- 2.8%
- ROE
- 4.5%
- Net margin
- 15.8%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−36.8% from the high
₩1,292Today: ₩1,675 – ₩1,769₩2,800
Returns
- 1W+12.3%
- 1M+3.7%
- 3M+1.8%
- 6M−30.6%
- YTD−30.9%
- 1Y−34.7%
- Volume today
- 76,569
- 2.0× the 20-day average
- Traded today
- ₩134M
- Listed shares
- 30,010,576
- EPS (12 months)
- ₩124
- Earnings yield 7.0%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Normal- BuzzNormalBuzz 57: heavy trading.
- MomentumFlat3% over the last month; the price is above its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
P&K Skin Research Center stock overview
P&K Skin Research Center (피엔케이피부임상연구센타, KRX: 347740) is listed on KOSDAQ, in the Business services sector. The company is a Korean research center that conducts human application tests and in-vitro tests to verify the safety, function, and efficacy of skin-applied products such as cosmetics, functional cosmetics, health functional foods, and beauty devices, excluding pharmaceuticals. Its shares closed at ₩1,769 on Oct 26, 2026, up 4.06% on the day, giving it a market value of ₩53B.
Key facts
- Market cap
- ₩53B
- Sector
- Business services
- Latest price change
- +4.06%
- As of
- Oct 26, 2026
- Main business
- The company is a Korean research center that conducts human application tests and in-vitro tests to verify the safety, function, and efficacy of skin-applied products such as cosmetics, functional cosmetics, health functional foods, and beauty devices, excluding pharmaceuticals.
Quick answers about P&K Skin Research Center
- What does P&K Skin Research Center do?
- The company is a Korean research center that conducts human application tests and in-vitro tests to verify the safety, function, and efficacy of skin-applied products such as cosmetics, functional cosmetics, health functional foods, and beauty devices, excluding pharmaceuticals. Its main revenue comes from cosmetic human application testing, followed by testing for health functional foods, beauty devices, and other goods, with customers including domestic and overseas cosmetics, beauty device, and health food manufacturers and sellers. It operates a head office in Yeouido, Seoul, and a branch in Bupyeong, Incheon.
- What is the market cap of P&K Skin Research Center?
- The market capitalisation of P&K Skin Research Center was ₩53B at the close on Oct 26, 2026.
- When is the next earnings report from P&K Skin Research Center?
- Korean companies rarely announce results dates in advance. Based on when P&K Skin Research Center filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
The company is a Korean research center that conducts human application tests and in-vitro tests to verify the safety, function, and efficacy of skin-applied products such as cosmetics, functional cosmetics, health functional foods, and beauty devices, excluding pharmaceuticals. Its main revenue comes from cosmetic human application testing, followed by testing for health functional foods, beauty devices, and other goods, with customers including domestic and overseas cosmetics, beauty device, and health food manufacturers and sellers. It operates a head office in Yeouido, Seoul, and a branch in Bupyeong, Incheon.
Written by AI from the company's latest annual report.
- Korean name
- 피엔케이피부임상연구센타
- Sector
- Business services
- Themes
- K-beauty
- CEO
- 박진오, 이해광(각자대표)
- Founded
- Oct 2010
- Listed
- Sep 2020
- Listed shares
- 30,010,576
- Fiscal year ends
- Month 12
- Website
- www.pnkskin.com
Similar companies
- S-1012750 · ₩3.5T₩93,300−2.81%
- Cheil Worldwide030000 · ₩2.2T₩19,170−1.13%
- Doosan Tesna131970 · ₩1.8T₩95,400−5.92%
- Lotte Tour Development032350 · ₩805B₩10,100−5.96%
- Soulbrain Holdings036830 · ₩737B₩35,950−3.36%
- Innocean Worldwide214320 · ₩691B₩17,270−1.99%
- Korea Ratings034950 · ₩458B₩100,800−0.20%
- GC005250 · ₩427B₩9,090−2.57%
Recent filings
See all- Half-year report (Jun 2026)Aug 14, 2026
- Investor relations (IR) eventJul 23, 2026
- Quarterly report (Mar 2026)May 15, 2026
- Corporate value-up planApr 1, 2026
- Annual general meeting resultsMar 31, 2026
Titles in Korean until English translations are added.
Also known as: P&K Skin Research Center / 피엔케이피부임상연구센타 / 347740 / KRX:347740
Source: KRX statistical information